Insiders · RPHM

RPHM insider transactions

Reneo Pharmaceuticals Inc. (RPHM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RPHM

• 607d
  President and CEO Saccomano Nicholas A was granted 4,556 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Director Phillips Andrew John

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Director Mathers Edward T

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Director Manke Isaac

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  Chief Financial Officer Leverone Jason A. was granted 16,331 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Director Jansen Valerie Malyvanh

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Chief Scientific Officer Hartley Dylan

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Director Grey Michael G

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  Director Carruthers R Michael was granted 4,939 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 4 filed by Chief Medical Officer Agresta Samuel

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Saccomano Nicholas A

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Phillips Andrew John

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Manke Isaac

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Leverone Jason A.

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Jansen Valerie Malyvanh

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Hartley Dylan

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Carruthers R Michael

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 607d
  SEC Form 3 filed by new insider Agresta Samuel

  3 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 620d
  Large owner Leonard Braden Michael bought $144,738 worth of shares (98,346 units at $1.47) (SEC Form 4)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 627d
  Large owner Leonard Braden Michael bought $76,237 worth of shares (56,106 units at $1.36) (SEC Form 4)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 630d
  Large owner Leonard Braden Michael bought $484,344 worth of shares (358,923 units at $1.35) (SEC Form 4)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 662d
  Large owner Leonard Braden Michael bought $380,598 worth of shares (271,826 units at $1.40) (SEC Form 4)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 753d
  Leonard Braden Michael bought $639,578 worth of shares (414,281 units at $1.54) (SEC Form 4)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 753d
  New insider Leonard Braden Michael claimed ownership of 3,692,963 shares (SEC Form 3)

  3 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1014d
  SEC Form 4: Hall Ashley exercised 15,625 shares at a strike of $1.80 and sold $98,058 worth of shares (15,625 units at $6.28)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1047d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1080d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1095d
  SEC Form 4 filed by Mathers Edward T

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Blunt Roshawn A.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Muralidhar Bali

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Seltzer Stacey Denenberg

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1096d
  SEC Form 4 filed by Dube Eric M

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1125d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1272d
  SEC Form 4 filed by Lam Jennifer

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1272d
  SEC Form 4 filed by Hall Ashley

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1272d
  SEC Form 4 filed by Flesher Gregory J.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1272d
  SEC Form 4: Dorenbaum Alejandro gifted 22,348 shares, decreasing direct ownership by 43% to 30,000 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1272d
  SEC Form 4 filed by Cruse Michael

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1375d
  SEC Form 4: Cruse Michael bought $25,448 worth of shares (7,500 units at $3.39)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1375d
  SEC Form 4: Grey Michael G exercised 50,000 shares at a strike of $1.97

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1377d
  SEC Form 4: Cruse Michael bought $23,243 worth of shares (7,255 units at $3.20), increasing direct ownership by 3% to 31,758 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1405d
  SEC Form 4 filed by Blunt Roshawn A.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1405d
  SEC Form 3 filed by new insider Blunt Roshawn A.

  3 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Mathers Edward T

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Seltzer Stacey Denenberg

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Dube Eric M

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Muralidhar Bali

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1466d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1524d
  SEC Form 3: New insider Lam Jennifer claimed ownership of 15,000 shares

  3 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1556d
  SEC Form 4 filed by Cruse Michael

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1596d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1596d
  SEC Form 3 filed by new insider Hoelscher Paul W.

  3 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1637d
  SEC Form 4: Jindal Vineet R. was granted 30,000 shares, increasing direct ownership by 455% to 36,600 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1637d
  SEC Form 4: Flesher Gregory J. was granted 100,000 shares, increasing direct ownership by 1,042% to 109,600 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1637d
  SEC Form 4: Dorenbaum Alejandro was granted 30,000 shares, increasing direct ownership by 134% to 52,348 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)